Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis
Clinical trial NCT00049764 · COMPLETED
Trial details
- NCT number
- NCT00049764
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 474
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.